Are there her2 + breast cancer clinical trials in New Jersey?

Yes. We're currently tracking 76 recruiting her2 + breast cancer studies with a site in New Jersey, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a her2 + breast cancer study in New Jersey?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in New Jersey to take part?

Not necessarily. These studies have a site in New Jersey, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a her2 + breast cancer trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · New Jersey

HER2 + Breast Cancer clinical trials in New Jersey

We’re tracking 76 recruiting her2 + breast cancer studies with a site in New Jersey — including Phase 1 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in New Jersey

NCT05059444Recruiting
Blood test to catch cancer early after treatment
This study looks for signs of cancer left in the body after treatment using a simple blood test (called a liquid biopsy). It aims to see if the test can catch cancer that might come back earlier than regular scans.
East Brunswick, New JerseyAges 18 years+
NCT05408845RecruitingPhase 2
Study drug vs standard care for HER2 salivary gland cancer
This Phase 2 trial tests how well ado-trastuzumab emtansine (and compares to two standard treatment options) works for salivary gland cancers that are HER2-positive or HER2-low. It aims to see whether the study drug can control cancer better and with acceptable side effects.
Basking Ridge, New JerseyAges 18 years+
NCT06623396RecruitingPhase 1
Mesothelin-targeted CAR T cells for esophagogastric cancer or mesothelioma
This trial tests a new treatment that uses your own immune cells (T cells) engineered to find and attack cancer cells that have a protein called mesothelin on their surface. It is for people with advanced or recurrent esophagogastric cancer (cancer of the esophagus or stomach) or malignant peritoneal mesothelioma (a rare cancer of the lining of the abdomen). The treatment involves collecting your T cells, modifying them in a lab, and then giving them back to you after a short course of chemotherapy to help them work.
Basking Ridge, New JerseyAges 18 years+
NCT06126276RecruitingPhase 2
Testing neratinib with or without palbociclib for HER2+ solid tumors
This trial tests two targeted drugs—neratinib alone or with palbociclib—for people with HER2-positive solid tumors (other than breast cancer) that have returned or not gone away. The goal is to see if blocking HER2 and CDK4/6 can shrink or slow the tumor.
Jersey City, New JerseyAges 18 years+

Where these studies are running in New Jersey

Institutions with a site for the recruiting her2 + breast cancer studies listed above.

Memorial Sloan Kettering Basking Ridge · 2 studies
Memorial Sloan Kettering Bergen · 2 studies
Memorial Sloan Kettering Monmouth · 2 studies
Astera Cancer Care
Community Medical Center
Jersey City Medical Center
Monmouth Medical Center
Monmouth Medical Center Southern Campus

What taking part in a her2 + breast cancer study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

HER2 + Breast Cancer trials in other states

Common questions

Are there her2 + breast cancer clinical trials in New Jersey?: Yes. We're currently tracking 76 recruiting her2 + breast cancer studies with a site in New Jersey, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a her2 + breast cancer study in New Jersey?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in New Jersey to take part?: Not necessarily. These studies have a site in New Jersey, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a her2 + breast cancer trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New her2 + breast cancer studies open in New Jersey regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.